Key result
Vascular pathology contributes to ~31% of all dementia cases globally.
Vascular dementia is highly prevalent, accounting for up to 31% of dementia cases when including mixed pathologies, highlighting an urgent need for improved recognition and preventive strategies.
There were 56.9 million people worldwide living with dementia in 2021, according to the Global Burden of Disease study, and this number is projected to exceed 137 million by 2050. Vascular dementia (VaD) is the second leading cause of dementia. While high-quality global epidemiological data on VaD remain limited, population-based studies with autopsy confirmation allow an approximate estimation. These show that pure VaD represents approximately 15% of all dementia cases, with mixed vascular and degenerative dementia accounting for an additional 16%. According to these estimates, approximately 8.5 million people worldwide suffer from pure VaD, and 9.1 million from mixed dementia. Under the assumption that existing proportional rates remain constant, the global burden of total VaD (i.e. pure VaD and mixed dementia) will reach 42.7 million cases by 2050. However, the impact of cerebrovascular disease is likely to be even greater. Increasing evidence demonstrates that vascular pathology commonly coexists with Alzheimer's and other neurodegenerative pathologies, increasing the risk that these neurodegenerative pathologies cause clinical dementia. Despite the importance of VaD, it remains underrecognized and underresearched compared to other forms of dementia. This fact sheet highlights the urgent need for improved recognition, standardized diagnostic approaches, and enhanced preventive strategies for this highly prevalent yet underrecognized cause of dementia. The factsheet has been reviewed and approved by the World Stroke Organization (WSO) executive.
No takes yet. Share an insight, caveat, or question.
Cai et al. (2026) conducted a review in Vascular dementia. Vascular dementia accounts for approximately 15% of all dementia cases globally, with mixed vascular and degenerative dementia accounting for an additional 16%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: